Results 191 to 200 of about 10,113 (218)
Some of the next articles are maybe not open access.
Clinical progress note: Invasive meningococcal disease
Journal of Hospital MedicineAbstract Invasive meningococcal disease due to Neisseria meningitidis in the United States has decreased since the late 1990s, leading to fewer practicing clinicians with first‐hand experience in diagnosing and managing of the disease.
Alaina Shine, Erin Chung
openaire +2 more sources
Be vigilant for invasive meningococcal disease.
The Practitioner, 2014Neisseria meningitidis is an encapsulated Gram-negative diplococcus which colonises the upper respiratory tract without causing symptoms in up to 25% of the population. At least 13 different serogroups cause invasive meningococcal disease (IND). In the UK serogroup B causes more than 80% of cases of invasive disease. More than 75% of cases occur in the
openaire +1 more source
THE EPIDEMIOLOGY AND CONTROL OF INVASIVE MENINGOCOCCAL DISEASE
The Pediatric Infectious Disease Journal, 1999openaire +2 more sources
Invasive Meningococcal Disease and Vaccines
Meningococcal diseases continue to have a major public health impact in many countries. Fatality rate of invasive meningococcal disease IMD in pediatric patients is 10 %. At least 75 % of cases of are caused byserogroups A, C, Y, and W-135; thus, IMD potentially is preventable by immu- nization.HANÇERLİ TÖRÜN, Selda, SALMAN, Nuran
openaire +1 more source
The burden of invasive meningococcal disease in the Netherlands, 2011–2020
Vaccine, 2023Marit Middeldorp +2 more
exaly
Global practices of meningococcal vaccine use and impact on invasive disease
Pathogens and Global Health, 2014Asad Ali, Keith P Klugman, Mary Ramsay
exaly